ITCI Annual Current Liabilities
$123.55 M
+$40.31 M+48.43%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual total current liabilities is $123.55 million, with the most recent change of +$40.31 million (+48.43%) on December 31, 2023. During the last 3 years, it has risen by +$86.69 million (+235.24%). ITCI annual current liabilities is now at all-time high.ITCI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Current Liabilities
$166.11 M
+$4.34 M+2.68%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly total current liabilities is $166.11 million, with the most recent change of +$4.34 million (+2.68%) on September 30, 2024. Over the past year, it has increased by +$63.02 million (+61.13%). ITCI quarterly current liabilities is now at all-time high.ITCI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.4% | +61.1% |
| 3 y3 years | +235.2% | +61.1% |
| 5 y5 years | +240.3% | +61.1% |
ITCI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.5% | at high | +211.3% |
| 5 y | 5-year | at high | +241.1% | at high | +434.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Intra-Cellular Therapies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $166.11 M(+2.7%) |
| June 2024 | - | $161.78 M(+20.0%) |
| Mar 2024 | - | $134.80 M(+9.1%) |
| Dec 2023 | $123.55 M(+48.4%) | $123.55 M(+19.8%) |
| Sept 2023 | - | $103.09 M(+12.0%) |
| June 2023 | - | $92.08 M(+15.7%) |
| Mar 2023 | - | $79.59 M(-4.4%) |
| Dec 2022 | $83.24 M(+56.0%) | $83.24 M(+7.5%) |
| Sept 2022 | - | $77.41 M(+9.6%) |
| June 2022 | - | $70.63 M(+19.6%) |
| Mar 2022 | - | $59.07 M(+10.7%) |
| Dec 2021 | $53.36 M(+44.8%) | $53.36 M(+6.9%) |
| Sept 2021 | - | $49.90 M(-1.0%) |
| June 2021 | - | $50.42 M(+27.0%) |
| Mar 2021 | - | $39.70 M(+7.7%) |
| Dec 2020 | $36.85 M(+1.7%) | $36.85 M(-3.1%) |
| Sept 2020 | - | $38.03 M(-5.5%) |
| June 2020 | - | $40.24 M(+29.5%) |
| Mar 2020 | - | $31.08 M(-14.2%) |
| Dec 2019 | $36.22 M(-0.2%) | $36.22 M(+8.5%) |
| Sept 2019 | - | $33.37 M(+2.6%) |
| June 2019 | - | $32.53 M(-2.9%) |
| Mar 2019 | - | $33.50 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $36.30 M(+155.5%) | $36.30 M(+24.6%) |
| Sept 2018 | - | $29.13 M(+53.8%) |
| June 2018 | - | $18.94 M(-3.7%) |
| Mar 2018 | - | $19.65 M(+38.3%) |
| Dec 2017 | $14.21 M(+34.9%) | $14.21 M(+19.7%) |
| Sept 2017 | - | $11.88 M(+70.6%) |
| June 2017 | - | $6.96 M(-57.3%) |
| Mar 2017 | - | $16.32 M(+54.9%) |
| Dec 2016 | $10.53 M(+68.2%) | $10.53 M(-92.5%) |
| Sept 2016 | - | $140.69 M(+625.9%) |
| June 2016 | - | $19.38 M(+116.6%) |
| Mar 2016 | - | $8.95 M(+42.8%) |
| Dec 2015 | $6.26 M(-40.7%) | $6.26 M(-39.7%) |
| Sept 2015 | - | $10.39 M(+11.5%) |
| June 2015 | - | $9.32 M(-36.1%) |
| Mar 2015 | - | $14.59 M(+38.2%) |
| Dec 2014 | $10.56 M(+54.5%) | $10.56 M(+195.1%) |
| Sept 2014 | - | $3.58 M(+30.6%) |
| June 2014 | - | $2.74 M(-30.0%) |
| Mar 2014 | - | $3.91 M(-42.8%) |
| Dec 2013 | $6.83 M(>+9900.0%) | $6.83 M(-12.1%) |
| Sept 2013 | - | $7.77 M(>+9900.0%) |
| June 2013 | - | $33.00 K |
| Mar 2013 | $26.20 K | - |
FAQ
- What is Intra-Cellular Therapies annual total current liabilities?
- What is the all time high annual current liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual current liabilities year-on-year change?
- What is Intra-Cellular Therapies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly current liabilities year-on-year change?
What is Intra-Cellular Therapies annual total current liabilities?
The current annual current liabilities of ITCI is $123.55 M
What is the all time high annual current liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual total current liabilities is $123.55 M
What is Intra-Cellular Therapies annual current liabilities year-on-year change?
Over the past year, ITCI annual total current liabilities has changed by +$40.31 M (+48.43%)
What is Intra-Cellular Therapies quarterly total current liabilities?
The current quarterly current liabilities of ITCI is $166.11 M
What is the all time high quarterly current liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly total current liabilities is $166.11 M
What is Intra-Cellular Therapies quarterly current liabilities year-on-year change?
Over the past year, ITCI quarterly total current liabilities has changed by +$63.02 M (+61.13%)